EMBOLIZE is a first-of-its-kind prospective, randomized control study on IR specialists' use of ovarian and pelvic vein embolization. 

The offering is from Ionic Health, which is based in São Paulo, Brazil, where the company has already tested the technology for three years. 

“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.  
 

“Surprisingly,” experts wrote in Nature Medicine, experience-based factors such as a physicians’ subspecialty or previous AI use failed to reliably predict the technology's impact. 

Black, Hispanic and Asian/Pacific Islander patients are significantly less likely to undergo an IR procedure for acute, pulmonary embolism. 

Medical 3D printing expert Summer Decker, PhD, University of South Florida, explains how her lab has helped improve patient care. 

"I'm struggling to understand the Luddite-level myopia around this topic," one radiation oncologist shared on social media. 

Radiology is facing increased regulatory pressure, underlining the need to improve how it interacts with members of this patient community.